Neurochemical Research 2005-01-01

Cerebrospinal fluid taurine after traumatic brain injury.

Yukio Seki, Masaaki Kimura, Nobuhiko Mizutani, Mitsugu Fujita, Yuri Aimi, Yoshio Suzuki

Index: Neurochem. Res. 30(1) , 123-8, (2005)

Full Text: HTML

Abstract

In the experimental setting, taurine is known to be released from swollen cells to reestablish their normal volume. However, its clinical relevance has not been fully understood. This study was undertaken to reveal changes in cerebrospinal fluid (CSF) amino acids concentration in patients with severe traumatic brain injury (TBI). The study included eight patients, in whom a ventricular catheter was inserted to measure intracranial pressure and obtain CSF samples for 5 days. CSF obtained from patients with normal pressure hydrocephalus served as a control. CSF taurine concentration increased 1.8 times control (P < 0.05) after TBI and returned to control value approximately 67 h after injury. Taurine decreased further and remained lower than control thereafter. Phosphoethanolamine showed similar increase, whereas glutamine decreased transiently and arginine remained close to control value. The present data support the period of astrocytic swelling observed after TBI in other morphological studies. The mechanism and consequences of CSF taurine decrease in the subacute stage of TBI need to be elucidated.


Related Compounds

Related Articles:

The CB₁ cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway.

2015-10-01

[Cell Death Differ. 22 , 1618-29, (2015)]

Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.

2015-01-01

[J. Neuroinflammation 12 , 110, (2015)]

Age-related reference values for urinary organic acids in a healthy Turkish pediatric population.

1994-06-01

[Clin. Chem. 40(6) , 862-6, (1994)]

Chemical genetics reveals a complex functional ground state of neural stem cells.

2007-05-01

[Nat. Chem. Biol. 3(5) , 268-273, (2007)]

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

2009-02-12

[Nature 457(7231) , 910-4, (2009)]

More Articles...